Bo O. Feng
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
Primary Aldosteronism: CXCR4- and FAP-Targeted PET/MR for Adrenal-Cardiac Axis.
Journal: Circulation. Cardiovascular imaging
Published: June 11, 2026
A blueberry-derived polysaccharide inhibits SARS-CoV-2 papain-like protease and exhibits broad-spectrum anti-coronavirus activity.
Journal: Natural product research
Published: June 09, 2026
Expression of concern to "Post-treatment with Resolvin D1 attenuates pulmonary hypertension by inhibiting endothelial-to-mesenchymal transition" [Biomed. Pharmacother. 177 (2024) 117023].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 23, 2026
Clinical Performance of a Novel 15.5-Day Factory-Calibrated Continuous Glucose Monitoring System in Adults With Diabetes.
Journal: Journal of diabetes science and technology
Published: May 18, 2026
Baicalin ameliorates podocyte injury and renal function impairment in idiopathic membranous nephropathy by inhibiting the AGE/RAGE signaling.
Journal: Renal failure
Published: April 20, 2026
Targeting Mitochondrial Complex I Protects Against Palmitic Acid-Induced Endothelial Dysfunction.
Journal: Diabetes, obesity & metabolism
Published: March 24, 2026
Correction: Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial.
Journal: Diabetologia
Published: March 19, 2026
The Combined Administration of Disulfiram and Baicalin Alleviates Membranous Nephropathy by Inhibiting Podocyte Inflammation and Pyroptosis.
Journal: Critical reviews in immunology
Published: February 19, 2026
The Rare Occurrence of Tissue PLA2R-Positive Membranous Nephropathy in a Patient With Sjögren's Syndrome and Renal Tubular Acidosis.
Journal: British journal of hospital medicine (London, England : 2005)
Published: November 24, 2025
Control of the cardiovascular risk factors in patients with type 2 diabetes mellitus in China in 2023-2024.
Journal: Diabetes, obesity & metabolism
Published: September 16, 2025
Effect of glucagon-like peptide-1 receptor agonists on cigarette smoking consumption in type 2 diabetes patients: study protocol of a randomized, parallel -controlled clinical trial.
Journal: Frontiers in clinical diabetes and healthcare
Published: July 14, 2025
Mazdutide versus placebo in Chinese adults with type 2 diabetes.
Journal: Nature
Published: June 16, 2025
Last Updated: 09/26/2026